Barry E. Greene - 16 Jun 2021 Form 4 Insider Report for Sage Therapeutics, Inc. (SAGE)

Role
President and CEO, Director
Signature
/s/ Jennifer Fitzpatrick, as Attorney-in-Fact for Barry Greene
Issuer symbol
SAGE
Transactions as of
16 Jun 2021
Net transactions value
+$495,627
Form type
4
Filing time
17 Jun 2021, 09:14:33 UTC
Previous filing
04 Jun 2021
Next filing
09 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SAGE Common Stock Purchase $495,627 +8,800 $56.32 8,800 16 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $56.12 USD to $56.41 USD. The price reported above reflects the weighted average purchase price. The issuer hereby undertakes to provide, upon request, to the SEC staff or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.